Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
TransMedics Group (TMDX) Stock Price & Analysis
258 Followers
TMDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.00 - $70.20
Previous Close$69.36
Volume297.17K
Average Volume (3M)344.68K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$204.46M
Total Debt (Recent Filing)$67.73M
Price to Earnings (P/E)-46.5
Beta1.11
Next EarningsMar 06, 2023
EPS Estimate-$0.3
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$65.75
EPS (TTM)-1.49
Shares Outstanding31,924,220
R-Squared0.15
Standard Deviation0.23
10 Day Avg. Volume402,691
30 Day Avg. Volume344,675
Price to Book (P/B)10.71
Price to Sales (P/S)33.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-39.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-5.20% Downside
Rating ConsensusStrong Buy
Alpha0.03
Number of Analyst Covering4
TransMedics Group News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMDX FAQ
What was TransMedics Group’s price range in the past 12 months?
TransMedics Group lowest stock price was $10.00 and its highest was $70.20 in the past 12 months.
What is TransMedics Group’s market cap?
Currently, no data Available
When is TransMedics Group’s upcoming earnings report date?
TransMedics Group’s upcoming earnings report date is Mar 06, 2023 which is in 30 days.
How were TransMedics Group’s earnings last quarter?
TransMedics Group released its earnings results on Nov 03, 2022. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.412 by $0.162.
Is TransMedics Group overvalued?
According to Wall Street analysts TransMedics Group’s price is currently Overvalued.
Does TransMedics Group pay dividends?
TransMedics Group does not currently pay dividends.
What is TransMedics Group’s EPS estimate?
TransMedics Group’s EPS estimate is -$0.3.
How many shares outstanding does TransMedics Group have?
TransMedics Group has 31,924,220 shares outstanding.
What happened to TransMedics Group’s price movement after its last earnings report?
TransMedics Group reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.412. Following the earnings report the stock price went up 23.997%.
Which hedge fund is a major shareholder of TransMedics Group?
Among the largest hedge funds holding TransMedics Group’s share is Driehaus Capital Management LLC. It holds TransMedics Group’s shares valued at 42M.
---
TransMedics Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$65.75
$65.75
Blogger Sentiment
Bullish
TMDX Sentiment 85%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 417.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 9.5%
Last 30 Days ▲ 9.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
377.68%
12-Months-Change
Fundamentals
Return on Equity
-31.67%
Trailing 12-Months
Asset Growth
109.59%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
TransMedics Group Inc
TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
---
---